Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AtriCure Inc announces definitive agreement to acquire estech


Thursday, 19 Dec 2013 04:05pm EST 

AtriCure Inc:Enters into a definitive merger agreement under which AtriCure has agreed to acquire Estech.Says for a cash-free, debt-free up-front payment of about 2.1 million shares or $34 million of AtriCure common stock and up to $26 million in additional consideration based on the achievement of certain revenue-based milestones.Says transaction is subject to customary closing conditions and is expected to close in the next several weeks. 

Company Quote

17.8
0.08 +0.45%
2:31pm EST